Furthermore, CYP26A1 overexpression was significantly associated with the primary tumor stage of carcinomas and pTNM stage (Table 2), suggesting that CYP26A1 was primarily correlated with primary tumor growth in HNC patients. This evidence concerns the gene CYP26A1 and carcinoma.